Medclair AB, a research and development company, specializes in the measurement, collection, and destruction of nitrous oxide (N2O). It offers mobile destruction unit, a solution that can be moved anywhere, where N2O is needed for pain relief; central destruction unit, a system designed for larger N2O destruction volumes; exhalation device that addresses the problem with residual levels of N2O in the patient’s exhalation; collection units for non-frequent use of N2O, and less frequent use or fitting in emergency services vehicles; and Nitrous Oxide Detector, an N2O measuring device for detecting the levels of N2O in the air. The company serves maternity wards, children’s healthcare, and dental care facilities. Medclair AB was incorporated in 2008 and is based in Stockholm, Sweden.
Metrics to compare | MCLR | Sector Sector - Average of metrics from a broad group of related Industrials sector companies | Relationship RelationshipMCLRPeersSector | |
---|---|---|---|---|
P/E Ratio | −102.1x | −1.3x | −0.6x | |
PEG Ratio | 0.24 | −0.05 | 0.00 | |
Price/Book | 2.1x | 3.0x | 2.6x | |
Price / LTM Sales | 2.4x | 5.5x | 3.2x | |
Upside (Analyst Target) | - | 107.3% | 40.6% | |
Fair Value Upside | Unlock | 13.6% | 7.1% | Unlock |